 This is accomplished with thiazolidinediones, a group of medications that activate nuclear receptor proteins responsible for lipid metabolism.The final strategy focuses on inhibiting the apoptotic pathways and signaling cascades.This is accomplished by using drugs that inhibit production of specific chemicals required for the pathways to be functional.